首页> 美国卫生研究院文献>Journal of Clinical Oncology >Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO T3a-bNO T4a-bNO and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E1697)

【2h】

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO T3a-bNO T4a-bNO and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E1697)

机译：T2bNOT3a-bNOT4a-bNO和T1-4N1a-2a（微观）黑色素瘤阶段4周大剂量干扰素-α-2b的三周随机研究：美国东部合作肿瘤小组的一项试验影像学网络癌症研究小组（E1697）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeTo test the efficacy of 4 weeks of intravenous (IV) induction with high-dose interferon (IFN) as part of the Eastern Cooperative Oncology Group regimen compared with observation (OBS) in patients with surgically resected intermediate-risk melanoma.

机译：目的为了比较经手术切除的中度危险性黑色素瘤患者，与东部观察（OBS）相比，作为东部合作肿瘤小组方案一部分的大剂量干扰素（IFN）静脉（IV）诱导4周的疗效。

著录项

期刊名称 Journal of Clinical Oncology
作者
Sanjiv S. Agarwala; Sandra J. Lee; Waiki Yip; Uma N. Rao; Ahmad A. Tarhini; Gary I. Cohen; Douglas S. Reintgen; Terry L. Evans; Joanna M. Brell; Mark R. Albertini; Michael B. Atkins; Shaker R. Dakhil; Robert M. Conry; Jeffrey A. Sosman; Lawrence E. Flaherty; Vernon K. Sondak; William E. Carson; Michael G. Smylie; Alberto S. Pappo; Richard F. Kefford; John M. Kirkwood;
展开▼
作者单位

展开▼
年(卷),期 -1(35),8
年度 -1
页码 885–892
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献

1. Phase III Randomized Study of 4 Weeks of High-Dose Interferon-alpha-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697) [J] . Agarwala Sanjiv S., Lee Sandra J., Yip Waiki, Journal of Clinical Oncology . 2017,第8期

机译：第III期在T2BNO，T3A-BNO，T4A-BNO和T1-4N1A-2A（微观）黑色瘤中4周高剂量干扰素-α-2B的随机研究：东方合作肿瘤学院学院的试验放射性影像网络癌症研究组（E1697）
2. Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697). [J] . David H Lawson, Sandra Lee, Fengmin Zhao, Journal of Clinical Oncology . 2015,第34期

机译：无局部证据的患者在完全手术切除后无病征兆晚期和/或IV期黑色素瘤：东部合作肿瘤小组-美国放射学院影像网络癌症研究小组（E4697）的试验。
3. Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design [J] . Kleinberg Lawrence R., Catalano Paul J., Forastiere Arlene A., International Journal of Radiation Oncology, Biology, Physics . 2016,第4期

机译：东部合作肿瘤小组和美国放射影像学院网络在食管腺癌中新辅助术前紫杉醇/顺铂/放疗（RT）或伊立替康/顺铂/ RT的第2期随机试验：长期结果及其试验设计意义
4. Randomized Placebo-Controlled Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E4697) [O] . David H. Lawson, Sandra Lee, Fengmin Zhao, -1

机译：在完全手术切除局部无疾病证据的患者中酵母衍生的粒细胞-巨噬细胞集落刺激因子（GM-CSF）对肽疫苗对GM-CSF加肽疫苗对安慰剂的随机安慰剂对照III期试验晚期和/或IV期黑色素瘤：东部合作肿瘤小组的一项试验-美国放射线影像学学院癌症研究小组（E4697）
5. Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205) [O] . Garg, Madhur K., Zhao, Fengmin, Sparano, Joseph A., 2017

机译：Cetuximab plus化疗放射治疗免疫功能正常的肛门癌患者：第二期东部合作肿瘤学组 - 美国放射学会影像网络癌症研究组试验（E3205）

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO T3a-bNO T4a-bNO and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E1697)

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅